TargetMol

Rimexolone

Product Code:
 
TAR-T34328
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T34328-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.
CAS:
49697-38-3
Formula:
C24H34O3
Molecular Weight:
370.533
Purity:
0.98
SMILES:
CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

References

Spies CM, Gaber T, Hahne M, Naumann L, Tripmacher R, Schellmann S, Stahn C, Burmester GR, Radbruch A, Buttgereit F. Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells. Immunol Lett. 2010 Jun 15;131(1):24-32. doi: 10.1016/j.imlet.2010.03.009. Epub 2010 Apr 2. PubMed PMID: 20363256. Kavuncu S, Horoz H, Ardagil A, Erbil HH. Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. Int Ophthalmol. 2008 Aug;28(4):281-5. Epub 2007 Aug 31. PubMed PMID: 17762913. Florea A, Zwart JE, Lee CW, Depew A, Park SK, Inman J, Wareham R, Johnson K, John E, Wall GM, Jung T. Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion. Acta Otolaryngol. 2006 Sep;126(9):910-5. PubMed PMID: 16864486. Vico-Ruiz E, Ben?tez-Del-Castillo-S?nchez JM, Cui?a-Sardi?a R, Mart?nez-De-La-Casa JM, Garc?a-S?nchez J. [0.1% dexamathasone and 1% rimexolone. A comparative study in the postoperative treatment after cataract extraction]. Arch Soc Esp Oftalmol. 2009 Jun;84(6):299-304. Spanish. PubMed PMID: 19568990.